Lessons learned from subretinal implant
Clinician researcher speaks to lessons learned from experience with subretinal visual implant
Cheryl Guttman Krader
Published: Monday, April 29, 2019
In March, 2019, shareholders of Retina Implant AG resolved to dissolve the company. Therefore, Retina Implant Alpha AMS, the company’s subretinal visual implant, will no longer be available for patients.
Looking back, however, valuable information can be gleaned from experience with the electronic retinal prosthesis and its earlier generation version (Retina Implant Alpha IMS), said Katarina Stingl MD at the annual meeting of the Association for Research in Vision and Ophthalmology in Vancouver, Canda.
Dr Stingl, University of Tübingen, Tübingen, Germany, has 12 years of clinical experience with the subretinal visual implants involving patients implanted in clinical trials and post-commercialisation. She highlighted four issues.
First, the subretinal implant can provide low vision restoration to patients with complete blindness from photoreceptor degeneration. The caveat, which was Dr Stingl’s second point, is that there are individual differences in outcomes.
Third, it was seen that foveal eccentricity (subfoveal versus parafoveal implant location) matters. Lastly, Dr Stingl said that the subretinal implant had a good clinical safety profile.
Tags: ARVO 2019
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.